Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 286

1.

Single-nucleotide polymorphisms of IL-10 and IL-28B as predictors of the response of IFN therapy in HCV genotype 4-infected children.

Shaker OG, Nassar YH, Nour ZA, El Raziky M.

J Pediatr Gastroenterol Nutr. 2013 Aug;57(2):155-60. doi: 10.1097/MPG.0b013e31828febf0.

PMID:
23880623
2.

Impact of IL-28B polymorphisms on pegylated interferon plus ribavirin treatment response in children and adolescents infected with HCV genotypes 1 and 4.

Domagalski K, Pawłowska M, Tretyn A, Halota W, Pilarczyk M, Smukalska E, Linkowska K, Grzybowski T.

Eur J Clin Microbiol Infect Dis. 2013 Jun;32(6):745-54. doi: 10.1007/s10096-012-1799-z. Epub 2013 Jan 13.

3.
4.

A single IL28B genotype SNP rs12979860 determination predicts treatment response in patients with chronic hepatitis C Genotype 1 virus.

Halfon P, Bourliere M, Ouzan D, Maor Y, Renou C, Wartelle C, Pénaranda G, Tran A, Botta D, Oules V, Castellani P, Portal I, Argiro L, Dessein A.

Eur J Gastroenterol Hepatol. 2011 Oct;23(10):931-5. doi: 10.1097/MEG.0b013e328349d0ef.

PMID:
21900787
5.

Relationship between the genetic variation in interleukin 28B and response to antiviral therapy in patients with chronic hepatitis C.

Xie JQ, Guo XY, Zhang XH, Lin BL, Xie DY, Gao ZL, Wang GS, Zhao ZX.

Chin Med J (Engl). 2012 Jul;125(13):2334-8.

PMID:
22882858
6.

The genotype CC of IL-28B SNP rs12979860 is significantly associated with a sustained virological response in chronic HCV-infected Pakistani patients.

Khubaib B, Saleem S, Idrees M, Afzal S, Wasim M.

J Dig Dis. 2015 May;16(5):293-8. doi: 10.1111/1751-2980.12238.

PMID:
25708904
7.

Interleukin-28B (IL-28B) single-nucleotide polymorphisms and interferon plus ribavirin treatment outcome in Italian chronically HCV-infected patients.

Riva E, Scagnolari C, Monteleone K, Selvaggi C, Picardi A, Mazzarelli C, Pizzigallo E, Vincenzi B, Carducci A, Antonaci S, Giannelli G, Antonelli G.

J Viral Hepat. 2012 Sep;19(9):650-3. doi: 10.1111/j.1365-2893.2012.01606.x. Epub 2012 Apr 1.

PMID:
22863269
8.

Interleukin 28B-related polymorphisms: a pathway for understanding hepatitis C virus infection?

Garcia RF, Moreira S, de Araújo Ramos AL, Ferreira LE, de Mattos AA, Tovo CV, Nader LA, Ramos JA, Rondinelli E, de Jesus Dominici A, Garcia CE, de Souza Leite Pinho M, Brandão-Mello CE, Villela-Nogueira CA, de França PH.

World J Gastroenterol. 2013 Nov 14;19(42):7399-404. doi: 10.3748/wjg.v19.i42.7399.

9.

The predictive value of IL28B rs12979860, rs11881222 and rs8099917 polymorphisms and IP-10 in the therapeutic response of Egyptian genotype 4 patients.

Derbala M, Rizk NM, Al-Kaabi S, John A, Sharma M, El-dweik N, Yakoob R, Pasic F, Almohanadi M, Alejji K, Abdelmola A, Butt M.

Virology. 2013 Sep;444(1-2):292-300. doi: 10.1016/j.virol.2013.06.025. Epub 2013 Jul 16.

10.

Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C virus.

Kobayashi M, Suzuki F, Akuta N, Sezaki H, Suzuki Y, Hosaka T, Kawamura Y, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Chayama K, Miyakawa Y, Kumada H.

J Gastroenterol. 2012 May;47(5):596-605. doi: 10.1007/s00535-012-0531-1. Epub 2012 Mar 23.

PMID:
22438096
11.

IL28B polymorphisms predict the response to chronic hepatitis C virus infection treatment in a Mexican population.

Martínez-Gómez LE, Chávez-Tapia NC, Burguete-García AI, Aguilar-Olivos N, Madrid-Marina V, Román-Bahena M, Orbe-Orihuela C, Misael U, Méndez-Sánchez N.

Ann Hepatol. 2012 Nov-Dec;11(6):876-81.

12.

The complete title: The effect of interleukin-28B rs12979860 polymorphism on the therapeutic response of Moroccan patients with chronic hepatitis C.

Nadia K, Hicham E, Reda TM, Nadia T, Elarbi B, Saâd E, Mimoun Z, Saâd M.

Gene. 2015 Aug 15;568(1):31-4. doi: 10.1016/j.gene.2015.05.010. Epub 2015 May 7.

PMID:
25958342
13.

Epstein-Barr virus and Interleukin-28B polymorphism in the prediction of response to interferon therapy in hepatitis C patients.

Zekri AR, Abdullah D, Osman A, El-Rouby MN, Zayed N, Esmat G, Elakel W, Hafez HA.

Arab J Gastroenterol. 2015 Sep-Dec;16(3-4):84-9. doi: 10.1016/j.ajg.2015.09.013. Epub 2015 Oct 31.

PMID:
26526510
14.

Potential genetic markers for prediction of treatment response in Egyptian children infected with HCV genotype 4.

Rady NH, Darwish RK, Mogahed EA, Mandour IA, Abo Youssef H, Sharaf SA, El-Karaksy HM.

Cytokine. 2015 Oct;75(2):349-55. doi: 10.1016/j.cyto.2015.04.005. Epub 2015 Apr 27.

PMID:
25936570
15.

Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients.

Sarrazin C, Susser S, Doehring A, Lange CM, Müller T, Schlecker C, Herrmann E, Lötsch J, Berg T.

J Hepatol. 2011 Mar;54(3):415-21. doi: 10.1016/j.jhep.2010.07.041. Epub 2010 Sep 22.

PMID:
21112657
16.

Is rs8099917 polymorphism of IL-28B gene a good predictor of response to therapy of HCV than rs12979860? An Egyptian study.

Shaker O, Rashad A, Abd El Aziz G, El Raziky M.

Cell Biochem Biophys. 2015 Jan;71(1):307-14. doi: 10.1007/s12013-014-0199-7.

PMID:
25115611
17.

Interleukin-28B polymorphisms on the SVR in the treatment of naïve chronic hepatitis C with pegylated interferon-α plus ribavirin: a meta-analysis.

Shi KQ, Liu WY, Lin XF, Fan YC, Chen YP, Zheng MH.

Gene. 2012 Oct 1;507(1):27-35. doi: 10.1016/j.gene.2012.07.026. Epub 2012 Jul 25.

PMID:
22842190
18.

IFNL3 (IL28B) and IFNL4 polymorphisms are associated with treatment response in Thai patients infected with HCV genotype 1, but not with genotypes 3 and 6.

Akkarathamrongsin S, Thong VD, Payungporn S, Poovorawan K, Prapunwattana P, Poovorawan Y, Tangkijvanich P.

J Med Virol. 2014 Sep;86(9):1482-90. doi: 10.1002/jmv.23957. Epub 2014 Apr 30.

PMID:
24782280
19.

Interleukin 28B gene polymorphisms in hepatitis C virus-related cryoglobulinemic vasculitis.

Sansonno D, Russi S, Serviddio G, Conteduca V, D'Andrea G, Sansonno L, Pavone F, Lauletta G, Mariggiò MA, Dammacco F.

J Rheumatol. 2014 Jan;41(1):91-8. doi: 10.3899/jrheum.130527. Epub 2013 Dec 1.

PMID:
24293567
20.

Impact of host IL28B rs12979860, rs8099917 in interferon responsiveness and advanced liver disease in chronic genotype 3 hepatitis C patients.

Firdaus R, Biswas A, Saha K, Mukherjee A, Chaudhuri S, Chandra A, Konar A, Sadhukhan PC.

PLoS One. 2014 Jun 10;9(6):e99126. doi: 10.1371/journal.pone.0099126. eCollection 2014.

Supplemental Content

Support Center